Introduction
Smooth muscle (S.M.) autoantibody, demonstrated by indirect immunofluorescence on cryostat sections of tissues containing smooth muscle fibres, is a recognized serological marker of autoimmune forms of chronic hepatitis (Doniach and Walker, 1969) , and is usually present also in the sera of patients with acute infectious hepatitis (Farrow et al., 1970) . S.M.-antibodypositive sera have been shown to react with a normal constituent of the membranes of certain cell types (Farrow et al., 1971) . Since the malignant transformation of cells is often associated with changes in the cell membrane we report here the results of a preliminary survey for this antibody in a variety of malignant disorders.
Materials and Methods
Patients' Sera.-To avoid effects resulting from therapy serum was taken before any form of treatment and stored at -20°C. Sera were examined from 80 patients with histologically The ages of the patients ranged from 1 to 76 years. Sera from 46 normal subjects aged 17-79 years were also examined.
Immunofluorescence.-Fluorescent staining was carried out by the indirect "sandwich" method. Serum diluted 1/10 was applied to 6-,u cryostat sections from a composite block of rat stomach, kidney, and liver for half an hour, and, after washing, the sections were treated with fluorescein-labelled monospecific antihuman globulin reagents directed at IgM or IgG. These were prepared from specific rabbit antihuman IgG and sheep antihuman IgM with fluorescein isothiocyanate (isomer 1) (B.D.H.) according to the procedure described by Holborow and Johnson (1967) . For both conjugates the ratio O.D.495: O.D.,80 was 1 1, and both were used at a dilution of 1/60. The sections were then examined for staining of smooth muscle fibres between the gastric glands, in the muscularis mucosae, and in the walls of arteries. Sera giving positive staining at these sites gave a polygonal pattern of staining around liver cells (Johnson et al., 1966) and also stained renal glomeruli (Whittingham et al., 1966) . All these five sites in rat tissue contain antigenic determinants in common with human smooth muscle (myometrium) (Farrow et al., 1971) , and we have shown that sera which stain rat smooth muscle also stain human myometrium. Positivity was assessed on a points system which has produced comparable results in the hands of different observers. Each of the five features described above was scored as follows: 0 = no staining, 1 = probable staining, 2 = definite staining, and 3 = brilliant staining, the total score for each serum being assessed out of a possible 15; 0-5 was regarded as negative, 6-9 as weak positive, and 10-15 as strong positive.
All positive sera were then titrated.
Microscopy.-Stained sections were examined with a Reichert Zetopan microscope equipped with an IQ light source, FITC-3 (Balzer) interference filter, a Wratten 12 secondary filter, and a cardioid dark ground condenser.
Absorption Tests.-Sera were diluted with an equal volume of phosphate-buffered saline (pH 7-2). One volume of this diluted serum was then mixed with four volumes of an extract of human myometrium in 50% glycerol (Jones et al., 1970) kindly supplied by Dr. U. Groschel-Stewart. The mixture was then incubated at 37°C for one hour. The supematant after centrifugation was tested as described above.
Results and Discussion Smooth muscle antibody at titres of 1/10 or more was found in 54 (67-5%) of the 80 patients and in 9 (20%) of 46 controls. It is of note that all the controls positive for S.M. antibody were under the age of 31; almost half the controls tested were over this age. The titres of S.M. antibody in the controls and the cancer patients are compared in Table I , and Fig. 1 shows the distribution of IgG and IgM antibody titres. The incidence of S.M. antibody ranged from 18/30 (60%h) in malignant of the breast (50%) and absent in patients with neuroblastoma and in the controls. This absence of antinuclear antibody in neuroblastoma may well reflect the resistance of the immune system in childhood to those autoantigenic stimuli that require impairment of thymus cell control for their humoral expression. Table II shows the distribution of antinuclear factor titres. (Fig.   2B ); a constituent of arterial walls in close relation to but distinct from the fibres of the smooth muscle coat; and the free luminal surfaces of the epithelial cells lining the gastric glands (Fig. 2C) and certain renal tubules (probably the collecting tubules). This new antibody was distinguishable from S.M. antibody though the two occurred together in the five positive sera from neuroblastoma. The pattern of staining produced by both antibodies was anatomically closely related in the liver, glomeruli, and arterial walls, but the new antibody did not stain the gastric muscularis mucosae nor the smooth muscle fibres between the gastric glands (Fig. 2D) Smooth muscle antibody seems to be present in most of the sera examined from patients with malignant disease. Since it has been shown that this antibody also reacts with a normal constituent of the cell membrane of some cell types (Farrow et al., 1971 ) the interaction of this antibody with tumour cell mem_ branes must obviously be excluded before the existence of tumour-specific antibodies can be recognized.
It is not clear at the present time how production of S.M. antibody is related to the presence of a tumour. Hitherto S.M. antibody has been reported chiefly in hepatic disease, and this might suggest that its demonstration in cancer patients is merely a manifestation of metastatic involvement of the liver. Preliminary examination of the clinical data relating to the patients with malignant melanoma does not support this explanation since S.M. antibody was found in six out of nine patients in whom the lesion was considered to be in the primary stage. The presence of S.M. antibody in this group of patients may also argue against necrosis as a significant factor in its production. Among other possibilities under investigation by us is that a change in the membrane of the malignant cell results in the exposure of an actomyosin-like antigen, or leads to its production in a more immunogenic form.
